Definition and Epidemiology

• AKA Paroxysmal hypercyanotic attacks, hypoxic spells, blue spells, or anoxic spells.
• Acute emergency requiring prompt recognition and intervention.
• Peak incidence between 2 and 6 months of age.
• Frequent occurrence before 2 years of age.
• Higher susceptibility in infants with mild resting cyanosis lacking homeostatic compensatory mechanisms (e.g., polycythemia).

Triggers and Precipitating Factors

• Spontaneous and unpredictable onset.
• Early morning occurrence immediately after awakening.
• Vigorous crying, agitation, or exertion.
• Feeding.
• Dehydration, fever, or pain.

Pathophysiology

graph TD
    A[Triggers: Crying, Feeding, Fever, Dehydration] --> B[Increased Catecholamines / Peripheral Vasodilatation]
    B --> C[Infundibular Spasm]
    B --> D[Decreased Systemic Vascular Resistance]
    C --> E[Decreased Pulmonary Blood Flow]
    D --> F[Increased Right-to-Left Shunt via VSD]
    E --> F
    F --> G[Severe Systemic Hypoxemia]
    G --> H[Metabolic Acidosis]
    H --> I[Stimulation of Respiratory Center]
    I --> J[Hyperpnea / Increased Venous Return]
    J --> F

• Acute decrease in pulmonary blood flow.
• Increased right-to-left shunting across ventricular septal defect.
• Infundibular spasm from increased circulating catecholamines.
• Activation of right ventricular mechanoreceptors secondary to decreased systemic venous return.
• Activation of left ventricular mechanoreceptors secondary to decreased pulmonary blood flow.
• Peripheral vasodilatation causing severe fall in systemic vascular resistance.
• Systemic hypoxia inducing severe metabolic acidosis.
• Acidosis stimulating respiratory center causing hyperpnea.
• Increased venous return from hyperpnea worsening right-to-left shunt (vicious cycle).

Clinical Features

• Inconsolable crying, restlessness, and severe irritability.
• Hyperpnea with deep and rapid breathing.
• Absence of significant subcostal recession despite hyperpnea.
• Progressive, deepening cyanosis.
• Gasping respirations.
• Disappearance or marked reduction of right ventricular outflow tract systolic ejection murmur.
• Episode duration ranging from a few minutes to several hours.
• Generalized weakness and sleep following brief episodes.

Differential Diagnosis of Cyanotic Episodes

• Cyanotic breath-holding spells (forced expiration during crying, age 6 months to 5 years).
• Pallid breath-holding spells (associated severe bradycardia, first 1-2 years of life).
• Acrocyanosis (peripheral cyanosis with cold exposure, normal pink mucous membranes).
• Respiratory disorders (variable partial pressure of oxygen, responsive to mechanical ventilation).
• Central nervous system disorders (hypoxia reversed with artificial ventilation).
• Persistent pulmonary hypertension of the newborn (improved hypoxia with hyperventilation).

Complications

• Syncope or loss of consciousness.
• Convulsions and seizures.
• Cerebral thrombosis, central nervous system infarction, hemiplegia.
• Intractable metabolic acidosis, shock, and respiratory failure.
• Death.

Management

Immediate Interventions

Reduce SVR and oxygen

• Knee-chest position on abdomen (increases systemic vascular resistance, increases systemic venous return).
• Loosening of constrictive clothing.
• Oxygen delivery via face mask or nasal cannula.

Calming the child

• Calming and holding the infant.
• Subcutaneous morphine (0.2 mg/kg).
• Intramuscular ketamine (3-5 mg/kg).
• Intranasal fentanyl or midazolam.

ACIDOSIS/dehydration correction

• Intravenous fluid bolus (10 mL/kg dextrose normal saline).
• Avoidance of premature, agitating blood draws.
• Transcutaneous oxygen saturation monitoring.
• Intravenous sodium bicarbonate (1-2 mEq/kg diluted 1:1 or in 10 mL/kg N/5 in 5% dextrose) for rapid metabolic acidosis correction.

Pharmacological Interventions (Refractory Spells)

BETA blockers

• Intravenous beta-blockade for infundibular spasm reduction and heart rate control.
• Intravenous propranolol (0.15-0.25 mg/kg given slowly, repeatable once in 15 minutes).
• Intravenous metoprolol (0.1 mg/kg slowly over 5 minutes, maximum 3 doses, followed by 1-2 mcg/kg/min infusion).
• Intravenous esmolol infusion.

VASOPRESSORS

• Vasopressor administration for systemic vascular resistance augmentation and forced pulmonary blood flow.
• Intravenous phenylephrine (5 mcg/kg bolus, 1-4 mcg/kg/min infusion).
• Intravenous methoxamine (0.1-0.2 mg/kg) or intramuscular methoxamine (0.1-0.4 mg/kg).
• Intravenous diazepam (0.2 mg/kg) or midazolam (0.1-0.2 mg/kg) for seizure management.

OTHERS

• Neuromuscular blockade, elective intubation, and mechanical ventilation for persistent spells.
• Preparation for palliative (e.g., Blalock-Taussig-Thomas shunt) or corrective surgery.

Post-Spell Care and Prevention

• Careful neurological examination and central nervous system imaging for focal deficits.
• Oral propranolol therapy (0.5-1.5 mg/kg every 6-8 hours) for resting saturation improvement and spell frequency reduction.
• Therapeutic or prophylactic iron supplementation (if hemoglobin <12 g/dL) for relative anemia correction and stroke risk reduction.
• Strict avoidance of dehydration.
• Detailed echocardiography for disease morphology delineation.
• Parental counseling regarding spell recurrence and precipitating factors (dehydration, fever, pain).
• Expedited elective surgical repair.